Ionis Pharmaceuticals Inc. Stock
Ionis Pharmaceuticals Inc. gained 2.720% today.
The stock is one of the favorites of our community with 62 Buy predictions and 1 Sell predictions.
With a target price of 80 € there is a hugely positive potential of 73.42% for Ionis Pharmaceuticals Inc. compared to the current price of 46.13 €.
Our community identified positive and negative aspects for Ionis Pharmaceuticals Inc. stock for the coming years. 0 users see the criterium "Worthwhile Investment for the next years" as a plus for the Ionis Pharmaceuticals Inc. stock. On the other hand our users think that "Worthwhile Investment for the next years" could be a problem in the future.
Pros and Cons of Ionis Pharmaceuticals Inc. in the next few years
Pros
?
S********** s********
?
G***** c******* t* c**********
?
B****
Cons
?
C******** o* t** e**********
?
W********* I********* f** t** n*** y****
?
M***** P*******
Tell us your opinion to access the 'Wisdom of the Crowds'
Performance of Ionis Pharmaceuticals Inc. vs. its peers
| Security | Change(%) | 1w | 1m | 1y | YTD | 3y | 5y |
|---|---|---|---|---|---|---|---|
| Ionis Pharmaceuticals Inc. | 2.720% | -9.692% | -35.456% | 20.726% | -33.917% | 19.632% | 43.391% |
| Ligand Pharmaceuticals | 1.600% | -3.759% | -6.569% | 122.609% | 54.217% | 319.672% | 167.056% |
| United Therapeutics | 1.540% | -3.421% | -6.635% | 76.247% | 5.055% | 105.352% | 189.613% |
| Novocure Ltd | -1.670% | -17.160% | -7.246% | 31.410% | 13.498% | -56.713% | -90.089% |
Comments
Ionis Pharmaceuticals (IONS) had its price target lowered by Wells Fargo & Company from $100.00 to $95.00. They now have an "overweight" rating on the stock.
Show more
Ratings data for IONS provided by MarketBeat
Ionis Pharmaceuticals (IONS) had its price target lowered by HC Wainwright from $125.00 to $115.00. They now have a "buy" rating on the stock.
Show more
Ratings data for IONS provided by MarketBeat
Ionis Pharmaceuticals (IONS) had its "buy" rating reaffirmed by HC Wainwright.
Show more
Ratings data for IONS provided by MarketBeat

